JPRN-C000000396已完成3 期
Validation study of new febrile neutropenia guideline-Comparative study between oral levofloxacin and parenteral cefepime in low-risk patients with febrile neutropenia - Treatment for FN in Low-Risk patients
Japan Febrile Neutropenia Study Group0 个研究点目标入组 200 人开始时间: 2006年4月4日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Poor-risk acute leukemia patients Isolation of microorganism resistant to the study drugs Past history of allergy to beta-lactum or study drugs Pregnant or lactating woman Age of 15 years or younger Antimicrobial treatment within 3 months prior to the study entry Allegenic hematopoietic stem cell transplantation
研究者
相似试验
已完成
3 期
Validation study VI of febrile neutropenia guideline 2004Febrile NeutropeniaJPRN-UMIN000000462Japan Febrile Neutropenia Study Group400
已完成
不适用
A clinical study of the usefulness of a neutrophil elastase inhibitor in patients with postoperative acute exacerbation of interstitial pneumonia complicated with lung cancerInterstitial pneumonia combine with lung cancerJPRN-UMIN000008862Department of Thoracic Surgery Juntendo University School of Medicine120
进行中（未招募）
不适用
Phase IV study to investigate neutrophil downregulation of Thy-1 by Raptiva® (Efalizumab) as a potential responder predictor in patients with moderate to severe plaque psoriasis - Responder Prediction StudyModerate to severe chronic plaque psoriasis (PASI = 12) failing to respond to, or with a contraindication to, or intolerant to other systemic therapies including cyclosporine, methotrexate and Psoralen ultraviolet light A (PUVA)MedDRA version: 8.1Level: LLTClassification code 10050576Term: Psoriasis vulgarisEUCTR2006-004547-35-DESerono GmbH
尚未招募
1 期
Functional evaluation of neutrophil of patients at high risk for infection treated with monocyte/ neutrophil apheresisJPRN-UMIN000012245Mie University Hospital40
尚未招募
1 期
Functional evaluation of neutrophil of patients at high risk for infection treated with multiple monocyte/ neutrophil aphaeresesulcerative colitis, large bowel perforation, esophageal cancer, colorectal cancerJPRN-UMIN000013269Mie University Graduate School of Medicine10